Infigo Lifesciences Private Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Infigo Lifesciences Private Limited - overview
Established
2017
Location
Mumbai, Maharashtra, India
Primary Industry
Healthcare Specialists
About
Based in Mumbai, India, Infigo Lifesciences Private Limited d. b. a Infigo Eyecare is a healthcare company specializing in vision care services. In December 2022, Infigo Lifesciences Private Limited raised INR 162.
88 million in this series A from 360 ONE including individual investors. Shridhar Thakur founded the firm. Infigo operates eye care hospitals and 3D eye clinics equipped with high-end diagnostic and treatment technologies. Services include general ophthalmology, pediatric eye care, retina treatments, and diabetic eye disease management.
The clinics offer comprehensive consultation, diagnostics, and dispensing services, aiming to deliver quality care through standardized protocols.
Current Investors
360 ONE
Primary Industry
Healthcare Specialists
Sub Industries
Optometrists & Opticians Products and Services
Website
www.infigoeyehospitals.com/
Total Amount Raised
Subscriber access only
Infigo Lifesciences Private Limited - timeline of key events
Infigo Lifesciences Private Limited - financials
| Fiscal Year Ended | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 4,478,831 | 50,369,854 | 76,475,882 | - | - | - |
| % Revenue Growth (YoY) | - | - | 1024.6% | 51.8% | - | - | - |
| EBITDA (USD) | (69,082) | (19,646,773) | (42,686,423) | (14,362,662) | - | - | - |
| Operating Income (USD) | (69,082) | (22,299,499) | (58,067,877) | (37,563,814) | - | - | - |
| Operating Margin | - | (497.9%) | (115.3%) | (49.1%) | - | - | - |
| % EBITDA Margin | - | (438.7%) | (84.7%) | (18.8%) | - | - | - |
| NET Income (USD) | (69,082) | (16,787,064) | (51,050,675) | (24,235,608) | - | - | - |
| % Net Margin | - | (374.8%) | (101.4%) | (31.7%) | - | - | - |
Infigo Lifesciences Private Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | Infigo Lifesciences Private Limited | - | ||||||||
| Buyout | Completed | Infigo Lifesciences Private Limited | - |
Displaying 1 - 2 of 2
Infigo Lifesciences Private Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.